Delivery Order SPE2DB24D2010-SPE2DB24FZXM1
Award Date
8/28/24
Potential Completion Date
8/29/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,419.76 firm fixed-price delivery order is for ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $53,424.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The delivery order contract is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of October 9, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL prefilled syringes. The $47,329 firm-fixed-price delivery order has a completion date of September 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, is supplying these critical medical products as part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Actemra Actpen 162 mg/0.9 ml medication. The contract is a delivery order with a firm fixed price, valued at $85,325.55, and has a period of performance through September 26, 2024. This award is not a set-aside contract. Amerisourcebergen, through its Corporate Office division, has been awarded multiple federal contracts and Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA), a major defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The $7,271.33 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication, to support military treatment facilities and other government healthcare programs. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen, through its extensive federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,397.75 Firm Fixed Price Delivery Order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Actemra Actpen, a medication used to treat certain autoimmune and inflammatory conditions. The fixed-price delivery order, valued at $2,328.36, was issued by the Defense Logistics Agency (DLA) and has a completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,649.47 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,628.82 firm fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award SPE2DB22D2206|SPE2DB24FKL19 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $23,546.56 firm fixed-price delivery order is for the supply of Actemra Actpen 162 mg/0.9 ml medication. The contract has a completion date of September 20, 2024 and does not include a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and...